{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:53:36Z","timestamp":1787756016246,"version":"build-2784847793"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T00:00:00Z","timestamp":1604707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T00:00:00Z","timestamp":1604707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.81973661"],"award-info":[{"award-number":["No.81973661"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Evidence based capacity building project of traditional Chinese Medicine","award":["(2019)-130"],"award-info":[{"award-number":["(2019)-130"]}]},{"name":"National key talents training project of TCM clinical characteristic technology inheritance","award":["(2018)-224"],"award-info":[{"award-number":["(2018)-224"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and aim<\/jats:title>\n                    <jats:p>The use of anti-inflammatory and analgesic drugs such as nonsteroidal anti-inflammatory drugs(NSAIDs) for treating acute gout has limitations, such as adverse reactions in the gastrointestinal tract and toxicity in the liver, kidney, and heart. Hence, a new safe and effective treatment approach needs to be explored to reduce the use of anti-inflammatory and analgesic drugs, incidence of adverse reactions, and patients\u2019 burden. This randomized controlled clinical trial aimed to investigate the clinical efficacy and safety of the external application of compound Qingbi granules (CQBG) in treating acute gouty arthritis(AGA), providing evidence for designing a safe, effective, and optimized protocol for AGA comprehensive treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A total of 90 patients in line with the diagnostic standard of AGA were recruited and randomly divided into control, T1, and T2 groups (30 in each group). All the participators in the three groups all received Western-medicine-basic treatment (low-purine diet, drinking water more than 2000\u00a0mL\/days, oral loxoprofen, and NAHCO\n                      <jats:sub>3<\/jats:sub>\n                      ). Besides, the T1 group received an external application of diclofenac diethylamine emulgel, while the T2 group received an external application of CQBG. The participants in the control group received single-use Western-medicine-basic treatment. With a treatment course of 7\u00a0days and a follow-up of 7\u00a0days, the three groups were compared in terms of primary outcome indicators, including swelling, pain improvement, and change in pain duration and secondary outcome indicators, including serum C-reactive protein (CRP) level, uric acid (UA) level, and change in the thickness of the inflammatory synovium of joints under ultrasound. Meanwhile, the safety of the protocol was evaluated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The three groups of patients had no apparent differences in age, body mass index, history of gout, complications, and so on before recruitment. A comparison between pretreatment and post-treatment revealed remarkable reductions in the arthralgia visual analog scale score(VAS) and the swelling score in the three groups after the treatment and the improvements in the T2 group were more significant than those in the T1 and control groups (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). Regarding the onset time of pain improvement and pain duration, the T2 group had more significant efficacy compared with the other two groups (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). The serum CRP and blood UA levels in the three groups significantly decreased after the treatment, but with no significant intergroup difference. The improvement in the thickness of the inflammatory synovium in joints tested by ultrasound was more significant in the T2 group than in the control group (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). For safety evaluations, no significant difference in the incidence of adverse events was found.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The external application of CQBG combined with Western-medicine-basic treatment in patients with AGA improved arthralgia and swelling, shortened the period of taking NSAIDs, and reduced the levels of CRP and serum UA. Its therapeutic effect was significantly better than the effect of single-use Western-medicine-basic treatment. The study provided evidence for the clinical application of CQBG combined with Western medicine in treating AGA.<\/jats:p>\n                    <jats:p>\n                      <jats:italic>Trial registration<\/jats:italic>\n                      : ChiCTR, ChiCTR1800018020. Registered 27 August 2018,\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.chictr.org.cn\/showproj.aspx?proj=27138\">https:\/\/www.chictr.org.cn\/showproj.aspx?proj=27138<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13020-020-00398-8","type":"journal-article","created":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T08:02:38Z","timestamp":1604736158000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Effects of external application of compound Qingbi granules on acute gouty arthritis with dampness-heat syndrome: a randomized controlled trial"],"prefix":"10.1186","volume":"15","clinical-trial-number":[{"clinical-trial-number":"chictr1800018020","registry":"10.18810\/chictr"}],"author":[{"given":"Shuang","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanyan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yantong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoshi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,7]]},"reference":[{"issue":"2","key":"398_CR1","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41584-018-0149-7","volume":"15","author":"LK Stamp","year":"2019","unstructured":"Stamp LK, Dalbeth N. Prevention and treatment of gout. Nat Rev Rheumatol. 2019;15(2):68\u201370.","journal-title":"Nat Rev Rheumatol"},{"key":"398_CR2","first-page":"762820","volume":"2015","author":"R Liu","year":"2015","unstructured":"Liu R, Han C, Wu D, Xia X, Gu J, Guan H, Shan Z, Teng W. Prevalence of hyperuricemia and gout in Mainland China from 2000 to 2014:a systematic review and meta-analysis. Biomed Res Int. 2015;2015:762820.","journal-title":"Biomed Res Int"},{"key":"398_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3899\/jrheum.140458","volume":"92","author":"MD Wechalekar","year":"2014","unstructured":"Wechalekar MD, Vinik O, Moi JH, Sivera F, van Echteld IA, van Durme C, Falzon L, Bombardier C, Carmona L, Aletaha D, Landew\u00e9 RB, van der Heijde DM, Buchbinder R. The efficacy and safety of treatments for acute gout: results from a series of systematic literature reviews including Cochrane reviews on intraarticular glucocorticoids, colchicine, nonsteroidal antiinflammatory drugs, and interleukin-1 inhibitors. J Rheumatol Suppl. 2014;92:15\u201325.","journal-title":"J Rheumatol Suppl."},{"key":"398_CR4","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1136\/annrheumdis-2016-209707","volume":"76","author":"P Richette","year":"2017","unstructured":"Richette P, Doherty M, Pascual E, et al. 2016 updated EULAR evidence-based recommendations for the managementof gout. Ann Rheum Dis. 2017;76:2942.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"398_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.amjmed.2010.09.012","volume":"124","author":"RT Keenan","year":"2011","unstructured":"Keenan RT, O\u2019Brien WR, Lee KH, Crittenden DB, Fisher MC, Goldfarb DS, Krasnokutsky S, Oh C, Pillinger MH. Prevalence of contraindications and prescription of pharmacologic therapies for gout[J]. Am J Med. 2011;124(2):155\u201363. https:\/\/doi.org\/10.1016\/j.amjmed.2010.09.012.","journal-title":"Am J Med"},{"key":"398_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2165\/00002512-200724010-00002","volume":"24","author":"KT Hoskison","year":"2007","unstructured":"Hoskison KT, Wortmann RL. Management of gout in older adults: barriers to optimal control. Drugs Aging. 2007;24:21\u201336.","journal-title":"Drugs Aging"},{"key":"398_CR7","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.2174\/1381612053764922","volume":"11","author":"HF Cheng","year":"2005","unstructured":"Cheng HF, Harris RC. Renal effects of non-steroidal anti-inflammatory drugs and selective cyclooxygenase-2 inhibitors. Curr Pharm Des. 2005;11:1795\u2013804.","journal-title":"Curr Pharm Des"},{"key":"398_CR8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11926-007-0020-3","volume":"9","author":"WB White","year":"2007","unstructured":"White WB. Cardiovascular risk, hypertension, and NSAIDs. Curr Rheumatol Rep. 2007;9:36\u201343.","journal-title":"Curr Rheumatol Rep"},{"key":"398_CR9","unstructured":"Schimmer BP, Parker KL. Adrenocorticotropic Hormone: Adrenocortical Steroids and Their Synthetic Analogs: Inhibitors of the Synthesis and Actions of Adrenocortical Hormones. In: Goodman & Gillman\u2019s Pharmacology. Brunton LL, editor. 11th ed. 2006, Chapter 59. McGraw-Hill Medical Pub. Division: New York. e-book accessed January 10, 2009."},{"key":"398_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/art.22466","volume":"57","author":"HK Choi","year":"2007","unstructured":"Choi HK, Ford ES, Li C, Curhan G. Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. Arthritis Rheum. 2007;57:109\u201315.","journal-title":"Arthritis Rheum"},{"key":"398_CR11","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1093\/rheumatology\/ken305","volume":"47","author":"HK Choi","year":"2008","unstructured":"Choi HK, De Vera MA, Krishnan E. Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile. Rheumatology (Oxford). 2008;47:1567\u201370.","journal-title":"Rheumatology (Oxford)"},{"key":"398_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13020-020-0297-y","volume":"15","author":"X Chi","year":"2020","unstructured":"Chi X, Zhang H, Zhang S, Ma K, et al. Chinese herbal medicine for gout: a review of the clinical evidence and pharmacological mechanisms. Chin Med. 2020;15:17.","journal-title":"Chin Med"},{"issue":"02","key":"398_CR13","first-page":"159","volume":"43","author":"JY Huang","year":"2019","unstructured":"Huang JY, Zhang Y, Wu L, Li XP, Chen K. Analysis of tongue image in 216 patients with gout. J Shandong Univ Tradit Chin Med. 2019;43(02):159-62,66.","journal-title":"J Shandong Univ Tradit Chin Med."},{"issue":"05","key":"398_CR14","first-page":"256","volume":"50","author":"XL Wang","year":"2018","unstructured":"Wang XL, Liu N, Qin TN, Di PT, Li ZF, Peng JY. Professor Peng Jiangyun\u2019s experience in treating acute gout in dampness. J New Chin Med. 2018;50(05):256\u20137.","journal-title":"J New Chin Med"},{"issue":"01","key":"398_CR15","first-page":"73","volume":"35","author":"HH Wu","year":"2019","unstructured":"Wu HH, Liu X, Guo LZ, Ji B. Treatment of acute gout attack with integrated traditional Chinese and western medicine. J Changchun Univ Chin Med. 2019;35(01):73\u20135.","journal-title":"J Changchun Univ Chin Med"},{"issue":"04","key":"398_CR16","first-page":"69","volume":"36","author":"LZ Wang","year":"2018","unstructured":"Wang LZ. Effect of modified simiao Powder Decoction on inflammatory cytokines and multiple target regulatory signaling pathway for rats with acute gouty arthritis. J Sichuan Tradit Chin Med. 2018;36(04):69\u201372.","journal-title":"J Sichuan Tradit Chin Med"},{"issue":"04","key":"398_CR17","first-page":"6","volume":"25","author":"S Tian","year":"2019","unstructured":"Tian S, Miao MS. Mechanism of external use of traditional chinese medicine\"three micro-regulations for balance\"based on neural-endocrine-immune network. Chinese J Exp Tradit Med Formul. 2019;25(04):6\u201312.","journal-title":"Chinese J Exp Tradit Med Formul"},{"issue":"05","key":"398_CR18","first-page":"1033","volume":"42","author":"XK Li","year":"2019","unstructured":"Li XK, Feng S, Zheng YC, Liu M, Zhang J, Ma L. Research progress on chemical constituents and bioactivity of Phellodendri Chinensis Cortex and Phellodendri Amurensis Cortex. Drug Eval Res. 2019;42(05):1033\u20137.","journal-title":"Drug Eval Res."},{"key":"398_CR19","first-page":"27","volume":"04","author":"SG Xiong","year":"1992","unstructured":"Xiong SG, Zhang YJ, Fu WX, Zhang XC, Li ZL, Zhong ZH, Zhu YX. Clinical observation on 263 cases of soft tissue injury treated by Touguxiang massage cream. J Guiyang Univ Tradit Chinese Med. 1992;04:27\u20139.","journal-title":"J Guiyang Univ Tradit Chinese Med"},{"issue":"2","key":"398_CR20","first-page":"145","volume":"30","author":"X Wang","year":"1998","unstructured":"Wang X, Cui JR, Xiao ZP, Zhang YY, Li CL, Zhao YY, Cai SQ. A comparative study on the anti-inflammatory and analgesic effects of Tougucao. J Beijing Med Univ. 1998;30(2):145.","journal-title":"J Beijing Med Univ"},{"issue":"7","key":"398_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11926-016-0594-8","volume":"18","author":"AB Vargas-Santos","year":"2016","unstructured":"Vargas-Santos AB, Taylor WJ, Neogi T. Gout Classification Criteria: Update and Implications. Curr Rheumatol Rep. 2016;18(7):46.","journal-title":"Curr Rheumatol Rep"},{"key":"398_CR22","doi-asserted-by":"crossref","unstructured":"Zhao H ,Miao MS. A Review of the Method of External Treatment of Traditional Chinese Medicine[P]. 3rd International Conference on Green Materials and Environmental Engineering (GMEE 2017),2017.","DOI":"10.12783\/dteees\/gmee2017\/16626"},{"key":"398_CR23","first-page":"56973","volume":"41","author":"JA Singh","year":"2014","unstructured":"Singh JA, Taylor WJ, Dalbeth N, et al. OMERACT endorsement of measures of outcome for studies of acute gout. J Rheumatol. 2014;41:56973.","journal-title":"J Rheumatol"},{"issue":"09","key":"398_CR24","first-page":"75","volume":"26","author":"LIU Yi-feng","year":"2020","unstructured":"Yi-feng LIU, Lei CAO, Hua YANG, Yang-yang ZHEN. Influence of addition and subtraction therapy of yiyiren tang with external application therapy to inflammatory factors of patients with Acute Gouty Arthritis with Damp-heat Obstruction Syndrome[J]. Chinese Journal of Experimental Traditional Medical Formulae. 2020;26(09):75\u201380.","journal-title":"Chinese Journal of Experimental Traditional Medical Formulae"},{"key":"398_CR25","doi-asserted-by":"publisher","first-page":"810","DOI":"10.12659\/msm.895749","volume":"22","author":"L Xu","year":"2016","unstructured":"Xu L, Liu S, Guan M, Xue Y. Comparison of Prednisolone, Etoricoxib, and indomethacin in treatment of acute Gouty Arthritis: an open-label, randomized Controlled Trial. Med Sci Monit. 2016;22:810\u20137. https:\/\/doi.org\/10.12659\/msm.895749.","journal-title":"Med Sci Monit."},{"key":"398_CR26","doi-asserted-by":"crossref","unstructured":"Dinesh Khanna, Puja P.Khanna, John D.FitzGerald, Manjit K.Singh, Sangmee Bae, Tuhina Neogi, Michael H.Pillinger, Joan Merill, Susan Lee, Shraddha Prakash, Marian Kaldas, Maneesh Gogia, Fernando Perez-Ruiz, Will Taylor, Fr\u00e9d\u00e9ric Liot\u00e9, Hyon Choi, Jasvinder A.Singh, Nicola Dalbeth, Sanford Kaplan, Vandana Niyyar, Danielle Jones, Steven A.Yarows, Blake Roessler, Gail Kerr, Charles King, Gerald Levy, Daniel E.Furst, N.Lawrence Edwards, Brian Mandell, H.Ralph Schumacher, Mark Robbins, Neil Wenger, Robert Terkeltaub. 2012 American College of Rheumatology guidelines for management of gout. Part 2:therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res (Hoboken). 2012;64(10):1447\u201361.","DOI":"10.1002\/acr.21773"},{"issue":"9","key":"398_CR27","first-page":"1196","volume":"30","author":"HM Zhou","year":"2007","unstructured":"Zhou HM, Chen SQ, Sun BG, Yin LR, Ye XY, Chen ZX. A Clinical research of jiawei simiaosan oral administration combined with the external application of sihuangshuimi in the treatment of acute gouty arthritis. J Chin Med Mater. 2007;30(9):1196\u20138.","journal-title":"J Chin Med Mater."},{"issue":"7","key":"398_CR28","first-page":"791","volume":"12","author":"LZ Zhang","year":"2016","unstructured":"Zhang LZ, He HM, Li XF, Lv JS, Huang YH. Relationship between effect of tetrandrine on pleurisy and cAMP of inflammatory neutrophiles. Chinese Pharmacol Bull. 2016;12(7):791\u20136.","journal-title":"Chinese Pharmacol Bull"},{"key":"398_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13020-020-0288-z","volume":"15","author":"Y Gao","year":"2020","unstructured":"Gao Y, Wang F, Song Y, Liu H. The status of and trends in the pharmacology of berberine: a bibliometric review [1985\u20132018]. Chin Med. 2020;15:7.","journal-title":"Chin Med."},{"issue":"19","key":"398_CR30","first-page":"3304","volume":"29","author":"B Lin","year":"2016","unstructured":"Lin B. Compasion of the Nourishing Yin effect and anti-gout effect of unprocessed and different processed products of cortex phellodendri chinensis. J Med Theor Pra. 2016;29(19):3304\u20135.","journal-title":"J Med Theor Pra."},{"issue":"05","key":"398_CR31","first-page":"82","volume":"51","author":"F Yang","year":"2017","unstructured":"Yang F, Jin RM, Fan B, Zhang N, Yang LJ, He WQ, Fu SG. Experimental study on bacteriostatic and anti-inflammatory effects of Compound Tougucao Solution. SHJTCM. 2017;51(05):82\u20135.","journal-title":"SH.J.TCM."},{"issue":"2","key":"398_CR32","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1089\/jmf.2018.4259","volume":"22","author":"HR Kim","year":"2019","unstructured":"Kim HR, Kim BM, Won JY, Lee KA, Ko HM, Kang YS, Lee SH, Kim KW. Quercetin, a plant poyphenol, Has potential for the prevention of bone destruction in rheumatoid arthritis. J Med Food. 2019;22(2):152\u201361.","journal-title":"J Med Food"},{"key":"398_CR33","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.intimp.2017.11.013","volume":"54","author":"Y Yang","year":"2018","unstructured":"Yang Y, Zhang X, Xu M, Wu X, Zhao F, Zhao C. Quercetin attenuates collagen-induced arthritis by restoration of Th17\/Treg balance and activation of Heme Oxygenase 1-mediated anti-inflammatory effect. Int Immunopharm. 2018;54:153\u201362.","journal-title":"Int Immunopharm"},{"issue":"3","key":"398_CR34","first-page":"418","volume":"10","author":"JJ Ji","year":"2013","unstructured":"Ji JJ, Lin Y, Huang SS, Zhang HL, Diao YP, Li K. Quercetin:a potential natural drug for adjuvant treatment of rheumatoid arthritis. Afr J Tradit Compl Altern Med. 2013;10(3):418\u201321.","journal-title":"Afr J Tradit Compl Altern Med"},{"key":"398_CR35","first-page":"1794","volume":"23","author":"F Li","year":"2007","unstructured":"Li F, Yao JH, Tian YQ, Zhang FX, Sun LJ, Tao JM. Effect of sodium ferulate on the expression of VEGF and TNF-\u03b1 in serum of patients with rheumatoid arthritis. China Pharmacy. 2007;23:1794\u20136.","journal-title":"China Pharmacy"},{"issue":"11","key":"398_CR36","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.1002\/art.34644","volume":"64","author":"S Tarp","year":"2012","unstructured":"Tarp S, Bartels EM, Bliddal H, Furst DE, Boers M, Danneskiold-Samsoe B, Rasmussen M, Christensen R. Effect of nonsteroidal antiinflammatory drugs on the C-reactive protein level in rheumatoid arthritis: a meta-analysis of randomized controlled trials. Arthritis Rheum. 2012;64(11):3511\u201321. https:\/\/doi.org\/10.1002\/art.34644 (PMID: 22833186).","journal-title":"Arthritis Rheum"},{"key":"398_CR37","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3389\/fmed.2019.00214","volume":"6","author":"DD Pang","year":"2019","unstructured":"Pang DD, Dai SM. Non-steroidal anti-inflammatory drugs are unlikely to inhibit radiographic progression of ankylosing spondylitis: a systematic review. Front Med. 2019;6:214. https:\/\/doi.org\/10.3389\/fmed.2019.00214.","journal-title":"Front Med."},{"issue":"38","key":"398_CR38","first-page":"757","volume":"12","author":"R Shuang","year":"2019","unstructured":"Shuang R, Li-qiang Ni, Di M, Yan-tong L, Yun M, Fan-yan M, Ning T, Jie Z. Mechanisms of Cortex phellodendri-Herba tuberculate speranskia in treatment of rheumatoid arthritis based on network pharmacology[J]. Chin J New Drugs Clin Rem. 2019;12(38):757\u201366.","journal-title":"Chin J New Drugs Clin Rem"},{"key":"398_CR39","first-page":"CD010120","volume":"9","author":"CM van Durme","year":"2014","unstructured":"van Durme CM, Wechalekar MD, Buchbinder R, Schlesinger N, van der Heijde D, Landew\u00e9 RB. Non-steroidal anti-inflammatory drugs for acute gout. Cochrane Database Syst Rev. 2014;9:CD010120.","journal-title":"Cochrane Database Syst Rev."},{"issue":"3","key":"398_CR40","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.4049\/jimmunol.1300274","volume":"91","author":"SM Paulissen","year":"2013","unstructured":"Paulissen SM, van Hamburg JP, Davelaar N, et al. Synovial fibroblasts directly induce Th17 pathogenicity via the cyclooxygenase\/prostaglandin E2 pathway, independent of IL-23[J]. J Immunol. 2013;91(3):1364\u201372.","journal-title":"J Immunol"},{"issue":"9","key":"398_CR41","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.4155\/fmc.15.55","volume":"7","author":"CJ Malemud","year":"2015","unstructured":"Malemud CJ. The PI3K\/Akt\/PTEN\/mTOR pathway: a fruitful target for inducing cell death in rheumatoid arthritis[J]. Future Med Chem. 2015;7(9):1137\u201347.","journal-title":"Future Med Chem."},{"key":"398_CR42","doi-asserted-by":"crossref","first-page":"8095825","DOI":"10.1155\/2017\/8095825","volume":"2017","author":"SI Khan","year":"2017","unstructured":"Khan SI, Malhotra RK, Rani N, Sahu AK, Tomar A, Garg S, Nag TC, Ray R, Ojha S, Arya DS, Bhatia J. Febuxostat Modulates MAPK\/NF-\u03baBp65\/TNF-\u03b1 Signaling in Cardiac Ischemia-Reperfusion Injury. Oxid Med Cell Longev. 2017;2017:8095825.","journal-title":"Oxid Med Cell Longev"},{"issue":"03","key":"398_CR43","first-page":"418","volume":"41","author":"YZ Lv","year":"2010","unstructured":"Lv YZ, Hu QH, Wang X, Ou YZ, Kong LD. Effects of Ermiao Pill water extracts on imbalance of urate levels and its related genes and protein levels in hyperuricemic mice. Chinese Tradit Herbal Drugs. 2010;41(03):418\u201323.","journal-title":"Chinese Tradit Herbal Drugs"},{"issue":"5","key":"398_CR44","first-page":"61","volume":"36 Suppl 114","author":"SN Christiansen","year":"2018","unstructured":"Christiansen SN, \u00d8stergaard M, Terslev L. Ultrasonography in gout: utility in diagnosis and monitoring. Clin Exp Rheumatol. 2018;36 Suppl 114(5):61\u20137.","journal-title":"Clin Exp Rheumatol."}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-020-00398-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-020-00398-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-020-00398-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T22:35:50Z","timestamp":1723847750000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmjournal.biomedcentral.com\/articles\/10.1186\/s13020-020-00398-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,7]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["398"],"URL":"https:\/\/doi.org\/10.1186\/s13020-020-00398-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-39352\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-39352\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-39352\/v3","asserted-by":"object"}]},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,7]]},"assertion":[{"value":"1 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed following the standard of International Coordinating Committee on Global Partnerships and the revised edition of the Declaration of Helsinki. It was registered in ChiCTR (ChiCTR-TRC-13003200). Every participant endorsed informed consent voluntarily.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have provided consent for publication of the manuscript in the Journal of Chinese Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"117"}}